CRL vs GWW · rev $2.00B vs P/E 27, rev $9.76B
Charles River Laboratories (CRL) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
CRL currently screens at market cap $7.78B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the CRL and GWW stock pages for the full models.
Not investment advice.